These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 34997690)

  • 21. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging Therapeutic Promise of Ketogenic Diet to Attenuate Neuropathological Alterations in Alzheimer's Disease.
    Uddin MS; Kabir MT; Tewari D; Al Mamun A; Barreto GE; Bungau SG; Bin-Jumah MN; Abdel-Daim MM; Ashraf GM
    Mol Neurobiol; 2020 Dec; 57(12):4961-4977. PubMed ID: 32820459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target.
    Li RY; Qin Q; Yang HC; Wang YY; Mi YX; Yin YS; Wang M; Yu CJ; Tang Y
    Mol Neurodegener; 2022 Jun; 17(1):40. PubMed ID: 35658903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
    Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
    J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.
    Yao J; Irwin RW; Zhao L; Nilsen J; Hamilton RT; Brinton RD
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14670-5. PubMed ID: 19667196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.
    Yao J; Rettberg JR; Klosinski LP; Cadenas E; Brinton RD
    Mol Aspects Med; 2011 Aug; 32(4-6):247-57. PubMed ID: 22024249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.
    Cho S; Lee H; Seo J
    Mol Neurobiol; 2021 Jun; 58(6):2608-2619. PubMed ID: 33479841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.
    Kang S; Lee YH; Lee JE
    Yonsei Med J; 2017 May; 58(3):479-488. PubMed ID: 28332351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics.
    Han X
    J Neurochem; 2007 Nov; 103 Suppl 1(Suppl 1):171-9. PubMed ID: 17986152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid Biomarkers in Alzheimer's Disease.
    Zarrouk A; Debbabi M; Bezine M; Karym EM; Badreddine A; Rouaud O; Moreau T; Cherkaoui-Malki M; El Ayeb M; Nasser B; Hammami M; Lizard G
    Curr Alzheimer Res; 2018 Feb; 15(4):303-312. PubMed ID: 28474568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer's Disease.
    Jana A; Bhattacharjee A; Das SS; Srivastava A; Choudhury A; Bhattacharjee R; De S; Perveen A; Iqbal D; Gupta PK; Jha SK; Ojha S; Singh SK; Ruokolainen J; Jha NK; Kesari KK; Ashraf GM
    Mol Neurobiol; 2022 Jun; 59(6):3512-3528. PubMed ID: 35347587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions.
    Fabelo N; Martín V; Marín R; Moreno D; Ferrer I; Díaz M
    Neurobiol Aging; 2014 Aug; 35(8):1801-12. PubMed ID: 24613671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases.
    Hurley MJ; Deacon RMJ; Beyer K; Ioannou E; Ibáñez A; Teeling JL; Cogram P
    Pharmacol Ther; 2018 Aug; 188():36-44. PubMed ID: 29514054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.
    Butterfield DA; Bader Lange ML; Sultana R
    Biochim Biophys Acta; 2010 Aug; 1801(8):924-9. PubMed ID: 20176130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease.
    Monteiro-Cardoso VF; Oliveira MM; Melo T; Domingues MR; Moreira PI; Ferreiro E; Peixoto F; Videira RA
    J Alzheimers Dis; 2015; 43(4):1375-92. PubMed ID: 25182746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.